Acelyrin Inc (NASDAQ: SLRN) is -28.98% lower on its value in year-to-date trading and has touched a low of $1.85 and a high of $7.25 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The SLRN stock was last observed hovering at around $2.25 in the last trading session, with the day’s loss setting it -0.02%.
Currently trading at $2.23, the stock is -4.38% and -8.37% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.43 million and changing -0.89% at the moment leaves the stock -39.13% off its SMA200. SLRN registered -52.95% loss for a year compared to 6-month loss of -62.71%.
The stock witnessed a 1.36% gain in the last 1 month and extending the period to 3 months gives it a 4.69%, and is -10.08% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.48% over the week and 8.44% over the month.
Acelyrin Inc (SLRN) has around 83 employees, a market worth around $225.13M and $0.00M in sales. Distance from 52-week low is 20.87% and -69.24% from its 52-week high. The company has generated returns on investments over the last 12 months (-64.98%).
, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Acelyrin Inc (SLRN) Top Institutional Holders
The shares outstanding are 100.91M, and float is at 77.87M with Short Float at 4.58%.
The top institutional shareholder in the company is AYURMAYA CAPITAL MANAGEMENT COMPANY, LP with over 9.33 million shares valued at $41.17 million. The investor’s holdings represent 9.4136% of the SLRN Shares outstanding. As of 2024-06-30, the second largest holder is CITADEL ADVISORS LLC with 7.41 million shares valued at $32.68 million to account for 7.4732 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 5.27 million shares representing 5.3139% and valued at over $23.24 million, while VANGUARD GROUP INC holds 4.7835 of the shares totaling 4.74 million with a market value of $20.92 million.
Acelyrin Inc (SLRN) Insider Activity
The most recent transaction is an insider sale by Kim Mina, the company’s Chief Executive Officer. SEC filings show that Kim Mina sold 17,986 shares of the company’s common stock on Mar 17 ’25 at a price of $2.74 per share for a total of $49354.0. Following the sale, the insider now owns 0.67 million shares.
Acelyrin Inc disclosed in a document filed with the SEC on Mar 17 ’25 that Murugan Amar (Chief Legal Officer) sold a total of 3,913 shares of the company’s common stock. The trade occurred on Mar 17 ’25 and was made at $2.74 per share for $10737.0. Following the transaction, the insider now directly holds 0.12 million shares of the SLRN stock.
Still, SEC filings show that on Mar 17 ’25, Mpofu Shephard (Chief Medical Officer) disposed off 3,211 shares at an average price of $2.74 for $8811.0. The insider now directly holds 121,789 shares of Acelyrin Inc (SLRN).
